Lombard Odier Asset Management Europe Ltd Takes $4.16 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Lombard Odier Asset Management Europe Ltd purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 175,000 shares of the company’s stock, valued at approximately $4,163,000. Lombard Odier Asset Management Europe Ltd owned about 0.14% of Surgery Partners as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. DekaBank Deutsche Girozentrale raised its stake in shares of Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after acquiring an additional 1,375 shares during the period. EntryPoint Capital LLC raised its position in Surgery Partners by 257.1% in the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after purchasing an additional 4,607 shares during the period. Capstone Investment Advisors LLC purchased a new position in Surgery Partners during the 4th quarter worth $211,000. MeadowBrook Investment Advisors LLC lifted its holdings in shares of Surgery Partners by 15.9% in the 2nd quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company’s stock worth $293,000 after buying an additional 1,690 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in shares of Surgery Partners by 11.0% in the 2nd quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock worth $296,000 after buying an additional 1,237 shares during the period.

Analyst Ratings Changes

Several analysts recently weighed in on SGRY shares. Royal Bank of Canada restated an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a report on Wednesday, August 7th. Macquarie initiated coverage on shares of Surgery Partners in a report on Friday, June 28th. They issued an “outperform” rating and a $31.00 price target for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research note on Monday, August 19th. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Finally, Benchmark restated a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a report on Monday, August 26th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and an average target price of $39.86.

View Our Latest Stock Report on Surgery Partners

Surgery Partners Price Performance

Shares of SGRY opened at $32.57 on Monday. The company has a 50 day moving average of $30.22 and a two-hundred day moving average of $27.54. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. Surgery Partners, Inc. has a twelve month low of $22.05 and a twelve month high of $36.92. The company has a market cap of $4.14 billion, a price-to-earnings ratio of 45.30, a price-to-earnings-growth ratio of 2.44 and a beta of 2.76.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. The firm had revenue of $762.10 million during the quarter, compared to analyst estimates of $735.94 million. During the same quarter in the prior year, the business posted $0.25 EPS. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. As a group, analysts predict that Surgery Partners, Inc. will post 0.86 earnings per share for the current fiscal year.

Surgery Partners Company Profile

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.